And genetic testing in people with  rare disorders that prevent them from feeling pain have pinpointed several other  possible targets for drugs and perhaps eventually gene therapy.
Testes genéticos realizados em indivíduos com distúrbios raros que os impede de sentirem dor revelaram possíveis zonas alvo para fármacos e, eventualmente, para a terapia genética.